737 filings
Page 36 of 37
8-K
029zyb
19 Apr 05
Adventrx Presents Cofactor Toxicity and Pharmacodynamics Data from Phase Ii Trial
12:00am
8-K
s76u 0jumbqhl4c
15 Apr 05
Adventrx Granted Clearance In the Uk for Cofactor Phase Iib
12:00am
8-K
bz4dqb0hu1u9ts7n9
11 Apr 05
Adventrx’s Cofactor Phase Ii and Preclinical Toxicity Data to Be Presented at Aacr Annual Meeting
12:00am
8-K
9r2lo 8h7vdl8syl6bu
5 Apr 05
CORRECTING and REPLACING ADVENTRX ANNOUNCES 2004 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
12:00am
8-K
u9n9bl kpbko3fu
30 Mar 05
Adventrx Receives Cofactor Pancreatic Cancer Clinical
12:00am
8-K
skkbntt
7 Mar 05
Adventrx Announces Primary Endpoint
12:00am
8-K
xis6t94nfck
26 Jan 05
Other Events
12:00am
8-K
e6ob2qksoui 9y
13 Dec 04
ADVENTRX Pharmaceuticals Announces Senior Management
12:00am
10QSB
8q52v5mm0
15 Nov 04
Quarterly report (small business)
12:00am
8-K
0majru3i
15 Nov 04
ADVENTRX Pharmaceuticals Announces Third Quarter 2004 Results
12:00am
8-K
g7w x7or722jey30kmp
3 Nov 04
FDA Clears CoFactorTM to Begin Second Stage of Phase II Clinical Trial for Metastatic Colorectal Cancer
12:00am
424B3
lovnz
24 Sep 04
Prospectus supplement
12:00am
S-3/A
b0honkloqsfw7ib 9n
15 Sep 04
Shelf registration (amended)
12:00am
8-K
v2atz bzth
8 Sep 04
ADVENTRX Board of Directors Appoints Evan Levine President and CEO
12:00am
10QSB
m99i9kk1hebw5e0nktu
10 Aug 04
Quarterly report (small business)
12:00am
S-3
8ium5j
30 Jun 04
Shelf registration
12:00am
10QSB
1azk6e zkxuch7v9dt
12 May 04
Quarterly report (small business)
12:00am
8-A12B
x9spk3n5mua4jtcz9 ub
27 Apr 04
Registration of securities on exchange
12:00am
8-K/A
5qwf 5bp8ra0v
23 Apr 04
Changes in control of registrant
12:00am
REGDEX
jkv gi8mo192yib
20 Apr 04
Notice of sale of securities
12:00am